This clinical trial studies whether virtual reality (VR) can be used to improve anxiety in cancer patients during radiation therapy. Multiple studies have shown that patients with cancer who undergo radiation therapy experience anxiety at various timepoints throughout their treatment. VR is technology that creates immersive, computer-generated experiences. The VR used in this study delivers the computer-generated experiences to the patient through a headset. The headset allows the patient to select a relaxing video, which is designed to promote a calming experience and distract patients from the treatment process, prior to the radiation therapy session. The patient then wears the VR headset and watches the pre-selected video throughout the radiation treatment session. This may be an effective way to improve anxiety in cancer patients undergoing radiation therapy.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07324577.
Locations matching your search criteria
United States
North Carolina
High Point
Hayworth Cancer CenterStatus: Approved
Contact: Stephanie A. Parker
Phone: 336-781-2236
PRIMARY OBJECTIVES:
I. To quantify the proportion of participants who use the Meta Quest 2 Virtual Reality (VR) Headset device for the majority of radiation therapy visits.
II. To quantify the proportion of participant treatments in which the use of the Meta Quest 2 VR Headset maintained functionality for the duration of the treatment.
SECONDARY OBJECTIVES:
I. To investigate whether participants in the VR intervention group experienced a change in anxiety over time compared to the control group.
II. To evaluate acceptability of implementing the Meta Quest 2 VR Headset in the clinical workflow as an intervention during radiation therapy treatments for participants with cancer.
EXPLORATORY OBJECTIVES:
I. To assess adverse events specifically related to cybersickness from use of the Meta Quest 2 VR Headset during radiation therapy treatments for participants with cancer.
II. To evaluate changes in pre- and post-treatment anxiety over the course of treatment.
III. To measure participant satisfaction using the VR device over the course of treatment.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients wear the Meta Quest 2 VR Headset and watch a pre-selected relaxing video starting prior to each standard of care (SOC) radiation treatment setup and continuing throughout each radiation therapy session in the absence of disease progression or unacceptable toxicity on study.
ARM II: Patients receive SOC radiation therapy without VR headset for the duration of SOC radiation therapy in the absence of disease progression or unacceptable toxicity on study.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationWake Forest University Health Sciences
Principal InvestigatorStephanie A. Parker
